Publications by authors named "G Fiorentini"

Article Synopsis
  • The introduction of monoclonal antibodies targeting the CGRP pathway has significantly improved the treatment of episodic and chronic migraines, sparking hope for both doctors and patients.
  • This review focuses on real-world studies of three specific mAbs (erenumab, fremanezumab, and galcanezumab) to assess their practical effectiveness beyond clinical trials.
  • Findings from 61 studies indicate that these therapies show better efficacy, including reduced migraine frequency and pain intensity, while also demonstrating favorable safety and tolerability in everyday clinical practice.
View Article and Find Full Text PDF

Background: It is well known that laparoscopic liver surgery can offer advantages over open liver surgery in selected patients. However, what type of procedures can benefit most from a laparoscopic approach has been investigated poorly thus far. The aim of this study is thus to define the extent of advantages of laparoscopic over open liver surgery for lesions in the anterolateral (AL) and posterosuperior (PS) segments.

View Article and Find Full Text PDF

We conducted a multicenter, prospective study (EMBRACE) evaluating the real-life effectiveness, safety, and tolerability of eptinezumab (100 mg/300 mg)-a monoclonal antibody targeting the calcitonin-gene-related peptide (anti-CGRP mAb)-in high-frequency episodic migraine (HFEM) or chronic migraine (CM). The primary endpoint was the change in monthly migraine days (MMD) for HFEM or monthly headache days (MHD) for CM at weeks 9-12 compared to baseline. The secondary endpoints included changes in monthly analgesic intake (MAI), Numerical Rating Scale (NRS), Headache Impact Test (HIT-6), Migraine Disability Assessment Scale (MIDAS), Migraine Interictal Burden Scale (MIBS-4), and responder rates.

View Article and Find Full Text PDF

Background & Aims: Metabolic syndrome (MS) is a growing epidemic and a risk factor for the development of hepatocellular carcinoma (HCC). This study investigated the long-term outcomes of liver resection (LR) for HCC in patients with MS. Rates, timing, patterns, and treatment of recurrences were investigated, and cancer-specific survivals were assessed.

View Article and Find Full Text PDF